Create Account
D
AbCellera Biologics Inc. ABCL
$11.18 $0.171.54%
Recommendation
Sell
Prev Close
$11.18
Volume
1,253,830
Avg Vol (90D)
1,874,403
Market Cap
$3.20B
Dividend & Yield
--
52-Week Range
$5.42 - $14.97
P/E (TTM)
14.14
EPS (TTM)
$0.7908
My Lists My Alerts
Report
Rating
Reward
C
Fair
Risk
D
Weak
Rating Factors
Growth Index
Excellent
Efficiency Index
Good
Solvency Index
Excellent
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Is Now The Time To Put AbCellera Biologics (NASDAQ:ABCL) On Your Watchlist?
2/4/2023 - Simply Wall St
The 7 Most Undervalued Biotech Stocks to Buy in February 2023
2/2/2023 - InvestorPlace
AbCellera to Present at the SVB Securities Global Biopharma Conference on February 15, 2023
2/1/2023 - Business Wire
Quantbot Technologies LP Acquires 21,351 Shares of AbCellera Biologics Inc. (NASDAQ:ABCL)
1/31/2023 - Ticker Report
We Did The Math KOMP Can Go To $54
1/31/2023 - ETF Channel
AbCellera Biologics Inc. (NASDAQ:ABCL) Short Interest Update
1/30/2023 - Ticker Report
Short Interest in AbCellera Biologics Inc. (NASDAQ:ABCL) Rises By 29.9%
1/28/2023 - Zolmax
AbCellera to Report Full Year 2022 Financial Results on February 21, 2023
1/24/2023 - Business Wire
Is the Options Market Predicting a Spike in AbCellera (ABCL) Stock?
1/24/2023 - Zacks Investment Research
5 Best Healthcare Stocks For the Long Term
1/21/2023 - Insider Monkey
AbCellera Biologics Stock: Here's What's Coming in 2023
1/21/2023 - Motley Fool Canada
AbCellera Biologics Inc.'s (NASDAQ:ABCL) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
1/20/2023 - Simply Wall St
AbCellera Announces that the U.S. Patent Trial and Appeal Board Upholds Microfluidic Cell Culture Patent
1/20/2023 - Business Wire
AbCellera Biologics (ABCL, $10.54) Aroon Indicator entered a Downtrend on January 17, 2023.
1/18/2023 - Tickeron - Technical Analysis
SG Americas Securities LLC Has $1.59 Million Holdings in AbCellera Biologics Inc. (NASDAQ:ABCL)
1/16/2023 - Zolmax
Brokerages Set AbCellera Biologics Inc. (NASDAQ:ABCL) Target Price at $28.67
1/15/2023 - Ticker Report
Brokerages Set AbCellera Biologics Inc. (NASDAQ:ABCL) Target Price at $28.67
1/15/2023 - Zolmax
AbCellera Biologics (ABCL, $10.38) Aroon Indicator entered a Downtrend on January 13, 2023.
1/14/2023 - Tickeron - Technical Analysis
AbCellera Biologics (ABCL) Shares Cross Above 200 DMA
1/13/2023 - Market News Video
AbCellera Biologics (ABCL, $10.2) Aroon Indicator entered a Downtrend on January 12, 2023.
1/13/2023 - Tickeron - Stocks
Strength Seen in Pliant Therapeutics, Inc. (PLRX): Can Its 8.3% Jump Turn into More Strength?
1/12/2023 - Zacks Investment Research
AbCellera Biologics (ABCL, $9.6) Aroon Indicator entered a Downtrend on January 11, 2023.
1/12/2023 - Tickeron - Technical Analysis
AbCellera Biologics (ABCL, $9.38) Aroon Indicator entered a Downtrend on January 10, 2023.
1/11/2023 - Tickeron - Technical Analysis
5 AI Healthcare Stocks To Buy
1/10/2023 - Insider Monkey
AbCellera Biologics (ABCL, $9.55) Aroon Indicator entered a Downtrend on January 09, 2023.
1/10/2023 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$603.21M
EBITDA (TTM)
$353.87M
EBIT (TTM)
$335.84M
Net Income (TTM)
$248.36M
Balance Sheet
Total Assets (Q)
$1.55B
Total Debt (Q)
$76.11M
Total Liabilities (Q)
$302.24M
Book Value Per Share (Q)
$4.37
Cash Flow
Cash from Operations (TTM)
$229.74M
Cash from Investing (TTM)
-$336.71M
Cash from Financing (TTM)
-$143.00K
Net Change in Cash (TTM)
-$117.61M
Filings
Filing Date
Tuesday, November 8, 2022
Period Date
Friday, September 30, 2022
Next Filing
Week of Feb 20 and 24 (est)
Price History
Loading...
Beta
1.26
7-Day Total Return
6.27%
30-Day Total Return
5.47%
60-Day Total Return
-8.66%
90-Day Total Return
18.56%
Year to Date Total Return
17.81%
1-Year Total Return
20.22%
2-Year Total Return
-76.00%
3-Year Total Return
--
5-Year Total Return
--
52-week Low
May 12, 2022 - $5.42
52-week High
Nov 15, 2022 - $14.97
Valuation
Market Cap
$3.20B - Mid Cap
Enterprise Value
$2.41B
Price/Sales (TTM)
5.85
Price/Book (Q)
2.56
Dividends and Shares
Shares Outstanding
315.82M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.abcellera.com
Phone Number
Address
2215 Yukon Street
Vancouver, BC V5Y 0A1
Country
Canada
Year Founded
2012
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune... more
NASDAQ 02/03/2023 4:00PM Eastern Quotes delayed
Weiss Ratings